GSK's three-in-one inhaler gets positive opinion from EU agency


GlaxoSmithKline said on Friday that a European Medicines Agency panel has recommended the company's three-in-one inhaled lung drug. GSK's once-daily triple inhaler combines the drugs fluticasone furoate, umeclidinium and vilanterol.



from Biotech News